Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Almonertinib

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Glenmark Acquires Exclusive Multi-Regional Rights To Aumolertinib
    Glenmark Acquires Exclusive Multi-Regional Rights To Aumolertinib

    17 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/glenmark-secures-exclusive-multi-regional-rights-to-aumolertinib-from-hansoh-pharma-18579

    INDPHARMAPOST
    17 Dec 2025
    Share Share
    UK MHRA Approves Aumolertinib to Treat Non-Small Cell Lung Cancer
    UK MHRA Approves Aumolertinib to Treat Non-Small Cell Lung Cancer

    05 Jun 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/uk-mhra-approves-aumolertinib-to-treat-non-small-cell-lung-cancer-17247

    INDPHARMAPOST
    05 Jun 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.